HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical and ultrastructural study of histiocytosis X and non-X histiocytoses.

Abstract
The diagnostic reliability of ultrastructural and immunohistochemical examinations on routinely processed biopsy specimens of cutaneous histiocytic proliferations (histiocytosis X, n = 7; juvenile xanthogranuloma, n = 4; necrobiotic xanthogranuloma, n = 2; traumatic granuloma of the tongue, n = 1) was evaluated. S-100 protein, peanut agglutinin, and the antibody Mac-387 were used as markers for histiocytes. The frequency of Birbeck granule-containing cells in seven histiocytosis X lesions did not correspond with the number of S-100+ or peanut agglutinin+ cells. All neoplastic histiocytosis X cells were positive for S-100 protein and peanut agglutinin but were negative for Mac-387. Histiocytes of juvenile xanthogranuloma, necrobiotic xanthogranuloma, and traumatic granuloma were strongly positive for Mac-387 but were negative for S-100 protein and peanut agglutinin, except for the peanut agglutinin-reactive Touton giant cells. Mac-387 reliably differentiates histiocytic proliferations of the monocyte/macrophage system from those of the dendritic cell system. For the diagnosis of histiocytosis X, both S-100 protein and peanut agglutinin positivity in histiocytes is as reliable as ultrastructural demonstration of Birbeck granules.
AuthorsM Fartasch, N Vigneswaran, T L Diepgen, O P Hornstein
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 23 Issue 5 Pt 1 Pg. 885-92 (Nov 1990) ISSN: 0190-9622 [Print] United States
PMID2123893 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Female
  • Histiocytosis, Langerhans-Cell (metabolism, pathology)
  • Humans
  • Immunohistochemistry
  • Infant
  • Male
  • Middle Aged
  • Retrospective Studies
  • Skin (ultrastructure)
  • Skin Diseases (metabolism, pathology)
  • Xanthogranuloma, Juvenile (metabolism, pathology)
  • Xanthomatosis (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: